Live feed
Filing
SC 13D/A
SC 13D/A0000947871-24-000449·Corvus Pharmaceuticals, Inc.
Schedule 13D ownership disclosure
Corvus Pharmaceuticals Inc
Security class unavailable · CUSIP: 221015100
Event date: 2024-05-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,943,654
- Percent of class
- 11.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-24-000449
- Form type
- SC 13D/A
- Filer
- Corvus Pharmaceuticals, Inc.
- CIK
- CIK 1626971
- Filed
- May 08, 2024
- Reporting period
- May 06, 2024
- Description
- Schedule 13D beneficial ownership